Company Valuation: Edwards Lifesciences Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 80,883 46,128 46,246 43,663 49,471 52,349 - -
Change - -42.97% 0.25% -5.58% 13.3% 5.82% - -
Enterprise Value (EV) 1 80,616 45,956 45,198 40,285 45,843 48,718 47,154 45,338
Change - -42.99% -1.65% -10.87% 13.8% 6.27% -3.21% -3.85%
P/E 54.4x 30.6x 33.2x 10.6x 46.6x 36x 27.5x 24.7x
PBR 13.9x 7.82x 6.99x 4.36x 4.79x 4.93x 4.29x 3.98x
PEG - 12.14x -5.79x 0x -0.6x 1x 0.9x 2.1x
Capitalization / Revenue 15.5x 8.57x 7.7x 8.03x 8.15x 7.74x 7.04x 6.4x
EV / Revenue 15.4x 8.54x 7.53x 7.41x 7.56x 7.21x 6.35x 5.54x
EV / EBITDA 46.6x 23.7x 24.1x 24.1x 25.5x 22.8x 19.7x 17x
EV / EBIT 50.6x 25.6x 26.1x 26.6x 27.9x 24.7x 21.3x 18.3x
EV / FCF 57.3x 47.2x 47.9x 139x 34.3x 57.4x 29.3x 24.9x
FCF Yield 1.74% 2.12% 2.09% 0.72% 2.91% 1.74% 3.41% 4.01%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 2.38 2.44 2.3 6.97 1.83 2.523 3.299 3.681
Distribution rate - - - - - - - -
Net sales 1 5,232 5,382 6,005 5,440 6,068 6,761 7,431 8,177
EBITDA 1 1,729 1,936 1,879 1,670 1,800 2,137 2,395 2,668
EBIT 1 1,594 1,796 1,734 1,514 1,644 1,970 2,211 2,480
Net income 1 1,503 1,522 1,402 4,175 1,074 1,458 1,882 2,019
Net Debt 1 -267 -172.7 -1,048 -3,378 -3,628 -3,631 -5,195 -7,011
Reference price 2 129.55 74.61 76.25 74.03 85.25 90.82 90.82 90.82
Nbr of stocks (in thousands) 624,334 618,260 606,500 589,800 580,300 576,400 - -
Announcement Date 26/1/22 31/1/23 6/2/24 11/2/25 10/2/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
36x7.21x22.79x-.--% 52.35B
35.52x6x23.03x0.27% 256B
36.88x7x21.91x0.62% 163B
51.4x12.45x26.72x-.--% 155B
17.1x3.39x11.04x-.--% 65.3B
20.51x2.46x12.42x2.46% 51.93B
47.99x11.84x26.1x-.--% 50.75B
34.58x6.85x23.26x0.58% 50.04B
82.02x7.79x23.64x-.--% 46.03B
56.5x9.12x32.43x-.--% 42.2B
Average 41.85x 7.41x 22.34x 0.39% 93.26B
Weighted average by Cap. 40.16x 7.53x 22.64x 0.35%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Edwards Lifesciences Corporation

Historical PBR trend

Valuation ratios - PBR - Edwards Lifesciences Corporation

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Edwards Lifesciences Corporation

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Edwards Lifesciences Corporation


Year-on-year evolution of the Yield

Valuation ratios - Yield - Edwards Lifesciences Corporation
  1. Stock Market
  2. Stocks
  3. EW Stock
  4. Valuation Edwards Lifesciences Corporation